When it comes to disinfecting medical equipment in between patients, automated endoscopy reprocessors (AERs) are widely employed. AERs expose the internal tubes and exterior surfaces of reusable endoscopes to disinfecting chemicals.
Market expansion for automated endoscope reprocessors is anticipated to be driven by the rising prevalence of gastrointestinal (GI) illnesses requiring endoscopic operations. The number of gastrointestinal endoscopies conducted in the United States each year is close to 20 million, as of 2014 figures from the National Institutes of Health. Medical practitioners doing endoscopies are vulnerable to chemical and bodily fluid contamination from patients, damage to the musculoskeletal system, and radiation exposure. The risk of getting an infection during a gastrointestinal endoscopic surgery is roughly 1 in 1.8 million, according to a 2014 article in the International Journal of Surgery. Incomplete surveillance, silent infections, under-reporting, and long incubation period infections could all contribute to an underestimation of the true infection rate.
Automatic Endoscope Reprocessors (AERs) have largely replaced the need for a small number of human operators throughout this operation. AERs feature sinks designed for immersing endoscopes in HLD solution. AERs automatically clean the reprocessed endoscope with water to remove harmful HLD solution residues, and then uses forced air to dry the endoscope channels to prevent the growth of waterborne pathogenic germs during storage.
Over the next few years, the worldwide market for automated endoscope reprocessors is predicted to expand at a healthy CAGR of 6.7% from its 2022 value of US$ 845.3 m. (2023–2030).
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1916
Endoscope reprocessors are becoming increasingly used in healthcare settings, which are expected to fuel market expansion.
The global automated endoscopy reprocessor market is likely to be driven by the growing demand for automated endoscope reprocessors in hospitals for infection control. By standardizing numerous crucial reprocessing stages, AERs reduce the likelihood of human error and increase the reliability and consistency of endoscope reprocessing. The use of AERs decreases the likelihood that workers will be exposed to potentially dangerous chemical germicides during the reprocessing of endoscopes.
The global market for automated endoscopic reprocessors is growing as a result of a number of factors, including rising government concerns about patient safety and expanding healthcare infrastructure. For instance, in 2015, the CDC asked the Healthcare Infection Control Practices Advisory Committee (HICPAC) to publish recommendations for enhancing facility-level training to guarantee competency when reprocessing endoscopes.
The market is projected to expand as a result of the industry’s rising emphasis on product innovation.
The risk of infection during endoscopy can be further reduced by implementing a number of design adjustments to the sterile field, the AER, and the endoscope. Historically, improved functionality and performance were prioritized over HLD and cleaning simplicity while designing flexible gastrointestinal endoscopes. However, the duodenoscope’s intricate construction makes it more difficult to clean and perform HLD than other types of endoscopes. In particular, the FDA has requested that AERs that reprocess duodenoscopes check their reprocessing procedures.
Many high-profile recalls by industry leaders highlight the need for product improvements and new product development. Automatic endoscope reprocessors labeled for use with duodenoscopes include Cantel’s Medivators (Advantage Plus and DSD Edge) and Steris (System 1E Liquid Chemical Sterilant Processing System) in 2016. The same year, the group also approved an updated Olympus duodenoscope.
On top of that, the FDA mandated in November 2015 that Custom Ultrasonics recall all of its AERs from healthcare facilities due to the company’s violations of the FD&C Act, applicable regulations, and the Consent Decree. The government’s strict rules are projected to have a negative impact on market growth, but opportunities may arise from the need to recall products on a regular basis.
Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG are among the leading companies in the global automated endoscopic reprocessor market.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/1916
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Automated Endoscopy Reprocessor Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Automated Endoscopy Reprocessor Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/1916
Explore More Related Insights:
- Schizophrenia Therapeutic Market
- CNS Specific Antisense Oligonucleotide Market
- Adult and Pediatric Hemoconcentrators Market
- Neuroscience Market
- Phytochemical API Market
- Chemiluminescence Imaging Market
- Anticonvulsant Drugs Market
- Ophthalmic Viscoelastic Devices Market
- Minimally Invasive Surgery Market
- First Aid Kit Market
- Multi-Parameter Patient Monitoring Equipment Market
- Medical Commode Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837